These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

548 related items for PubMed ID: 22622176

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Natural history and clinical characteristics of CKD in type 1 and type 2 diabetes mellitus.
    Marshall SM.
    Adv Chronic Kidney Dis; 2014 May; 21(3):267-72. PubMed ID: 24780454
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM, Mauer M, International Diabetic Nephropathy Study Group.
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. High frequencies of diabetic micro- and macroangiopathies in patients with type 2 diabetes mellitus with decreased estimated glomerular filtration rate and normoalbuminuria.
    Ito H, Takeuchi Y, Ishida H, Antoku S, Abe M, Mifune M, Togane M.
    Nephrol Dial Transplant; 2010 Apr; 25(4):1161-7. PubMed ID: 19892756
    [Abstract] [Full Text] [Related]

  • 8. Studies of cardiovascular and renal function in subclinical and manifest diabetic nephropathy.
    Berglund J.
    Acta Med Scand Suppl; 1988 Apr; 722():1-69. PubMed ID: 3163465
    [Abstract] [Full Text] [Related]

  • 9. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK, Alves TP, Dwyer JP, Atkins R, de Zeeuw D, Cooper M, Shahinfar S, Lewis JB, Lambers Heerspink HJ.
    Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
    [Abstract] [Full Text] [Related]

  • 10. Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group.
    Nelson RG, Bennett PH, Beck GJ, Tan M, Knowler WC, Mitch WE, Hirschman GH, Myers BD.
    N Engl J Med; 1996 Nov 28; 335(22):1636-42. PubMed ID: 8929360
    [Abstract] [Full Text] [Related]

  • 11. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D.
    Semin Nephrol; 2007 Mar 28; 27(2):172-81. PubMed ID: 17418686
    [Abstract] [Full Text] [Related]

  • 12. Clinical impact of reducing microalbuminuria in patients with type 2 diabetes mellitus.
    Araki S, Haneda M, Koya D, Kashiwagi A, Uzu T, Kikkawa R.
    Diabetes Res Clin Pract; 2008 Nov 13; 82 Suppl 1():S54-8. PubMed ID: 18947896
    [Abstract] [Full Text] [Related]

  • 13. Diabetic kidney disease with and without albuminuria.
    Macisaac RJ, Jerums G.
    Curr Opin Nephrol Hypertens; 2011 May 13; 20(3):246-57. PubMed ID: 21422923
    [Abstract] [Full Text] [Related]

  • 14. Losartan in diabetic nephropathy.
    Perico N, Ruggenenti P, Remuzzi G.
    Expert Rev Cardiovasc Ther; 2004 Jul 13; 2(4):473-83. PubMed ID: 15225108
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15).
    Yokoyama H, Sone H, Oishi M, Kawai K, Fukumoto Y, Kobayashi M, Japan Diabetes Clinical Data Management Study Group.
    Nephrol Dial Transplant; 2009 Apr 13; 24(4):1212-9. PubMed ID: 18984626
    [Abstract] [Full Text] [Related]

  • 16. [Risk and prevention of diabetic nephropathy].
    Ravera M, Re M, Deferrari G.
    G Ital Nefrol; 2007 Apr 13; 24 Suppl 38():13-9. PubMed ID: 17922442
    [Abstract] [Full Text] [Related]

  • 17. Twelve shifting paradigms in diabetic renal disease and hypertension.
    Mogensen CE.
    Diabetes Res Clin Pract; 2008 Nov 13; 82 Suppl 1():S2-9. PubMed ID: 18947897
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
    Hughes DB, Britton ML.
    Pharmacotherapy; 2005 Nov 13; 25(11):1602-20. PubMed ID: 16232022
    [Abstract] [Full Text] [Related]

  • 19. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients.
    Cooper ME.
    J Hypertens Suppl; 1996 Dec 13; 14(6):S11-4. PubMed ID: 9023709
    [Abstract] [Full Text] [Related]

  • 20. Diabetic nephropathy--the family physician's role.
    Roett MA, Liegl S, Jabbarpour Y.
    Am Fam Physician; 2012 May 01; 85(9):883-9. PubMed ID: 22612183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.